Nissan, Uber, and UK startup Wayve will launch a self-driving taxi pilot program in Tokyo by late 2026, using electric vehicles equipped with automated systems.
Author: Aino Lehtinen
Aino Lehtinen
Aino Lehtinen is a Finnish journalist and editor originally from Helsinki, Finland. She studied Media and Communication Studies at the University of Tampere, where she developed a strong interest in investigative storytelling and cross-border journalism. After several years working with leading Finnish publications, she relocated to Berlin, Germany, where she currently lives and works as a freelance editor. Lehtinen focuses on issues such as digital privacy, press freedom, and the intersection of media and politics in Europe. Fluent in Finnish, English, and German, she often collaborates with international media outlets on transnational reporting projects.
European healthtech leader Alan secures €100M in funding, reaching €785M in annual recurring revenue and profitability in France as it aims to expand its AI-driven digital health platform.
Swedish-Norwegian startup Braive has raised SEK 30 million to enhance its AI-driven mental health tools across Europe, backed by notable investors.
Global venture capital funding saw a major shift in the first two months of 2026, with artificial intelligence and clean energy leading cross border investments.
Braive, a mental health startup based in Stockholm and Oslo, has successfully raised SEK 30 million to fuel its expansion across Europe.
Palmer Luckey’s gaming startup ModRetro is currently negotiating a major funding round aiming for a one billion dollar valuation after the successful Chromatic debut.
A pioneering Swedish startup is making headlines for its innovative use of drones to deliver life-saving defibrillators to cardiac arrest victims in under three minutes.
OpenAI has released GPT-5.4, a frontier model featuring autonomous computer-use capabilities and a 1-million token context window for professionals.
The biotech company Antiverse has raised $9.3 million in funding, aiming to revolutionize treatments for diseases that currently lack effective solutions.
The BioInnovation Institute (BII) has announced an additional €1.3 million in follow-on funding to support five innovative startups in its portfolio.